Home
|
Help
|
Contact
Sign in
WPRIM Management System>
DCMS
>
Journal of Gynecologic Oncology
>
2017
>
28
>
4
Volume:
28
Issue:
4
1. Risk factors for unrecognized invasive carcinoma in patients with vulvar high-grade squamous intraepithelial lesion at vulvoscopy-directed biopsy.
Page:e27—
2. Sentinel lymph node mapping with indocyanine green in vaginal cancer.
Page:e29—
3. High-risk human papillomavirus genotype distribution and attribution to cervical cancer and precancerous lesions in a rural Chinese population.
Page:e30—
4. Adult granulosa cell tumors of the ovary: a retrospective study of 30 cases with respect to the expression of steroid synthesis enzymes.
Page:e31—
5. Universal tolerance of nab-paclitaxel for gynecologic malignancies in patients with prior taxane hypersensitivity reactions.
Page:e38—
6. Germline and somatic mutations in homologous recombination genes among Chinese ovarian cancer patients detected using next-generation sequencing.
Page:e39—
7. Impact of time interval between radical hysterectomy with pelvic node dissection and initial adjuvant therapy on oncological outcomes of early stage cervical cancer.
Page:e42—
8. Prognostic value of metabolic parameters determined by preoperative ¹⁸F-FDG PET/CT in patients with uterine carcinosarcoma.
Page:e43—
9. Safety of ovarian preservation in premenopausal women with stage I uterine sarcoma.
Page:e46—
10. Prognostic factors and treatment outcomes in surgically-staged non-invasive uterine clear cell carcinoma: a Turkish Gynecologic Oncology Group study.
Page:e49—
11. Opportunistic bilateral salpingectomy during benign gynecological surgery for ovarian cancer prevention: a survey of Gynecologic Oncology Committee of Japan Society of Obstetrics and Gynecology.
Page:e52—
12. Update on rare epithelial ovarian cancers: based on the Rare Ovarian Tumors Young Investigator Conference.
Page:e54—
13. Genotype-specific methylation of HPV in cervical intraepithelial neoplasia.
Page:e56—
14. Ovarian needle aspiration in the diagnosis and management of ovarian masses.
Page:e40—
15. Survival outcomes after extensive cytoreductive surgery and selective neoadjuvant chemotherapy according to institutional criteria in bulky stage IIIC and IV epithelial ovarian cancer.
Page:e48—
16. Role and clinical application of next-generation sequencing (NGS) for ovarian cancer.
Page:e51—
17. Should national societies recommend opportunistic salpingectomy?.
Page:e53—
18. Surgical management of non-invasive uterine clear cell carcinoma.
Page:e55—
19. Ovarian conservation for young women with clinical stage IB–IIB cervical cancer in Japan.
Page:e60—